Dr. James Crowe, Director of the Vanderbilt Vaccine Center and Chief Scientist of Ahead100 described the benefits of monoclonal antibody treatment to Paul Sweeney and Matt Miller on "Bloomberg Markets: America."
Watch the video on the Yahoo Finance website.